Skip to content

A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases

A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06709690
Enrollment
35
Registered
2024-11-29
Start date
2024-10-25
Completion date
2025-12-31
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatric Patients

Keywords

18F-FDG PET/MR, pediatric, silent scan, flexible coil, deep learning

Brief summary

To investigate the feasibility of deep learning-assisted rapid silent PET/MR in pediatric applications.

Detailed description

This study aims to address the challenges faced by PET/MR in pediatric applications by leveraging new technologies such as flexible coils, silent sequences, and deep learning-based image reconstruction. The objective is to provide a rapid, silent, comfortable, and half-dose PET/MR imaging solution for pediatric patients, and to demonstrate its feasibility in this patient population.

Interventions

None listed

Sponsors

Ruijin Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Children who have clinical symptoms and are suspected of having malignant tumors after being evaluated by clinical pediatricians and require 18F-FDG PET/MR examination to further clarify their conditions. 2. Signed and dated informed consent form 3. Commit to complying with the research procedures and cooperate in the implementation of the entire research process. 4. No gender restriction, aged between 0 and 18 years old.

Exclusion criteria

1. Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc. 2. Patients with severe claustrophobia,epileptic seizures, respiratory distress who cannot lie down, and patients with mental anomalies who are unable to cooperate. 3. Patients with metal implants such as pacemakers, artificial metal heart valves, and neurostimulators in their bodies. 4. Non-compliant person.

Design outcomes

Primary

MeasureTime frameDescription
Lesion detection rate1 yearRoutine laboratory or imaging tests or pathology are performed based on clinical needs to assess the accuracy, sensitivity and specificity of rapid silent 18F-FDG PET/MR for lesion detection.
Completion of PET/MR examinations1 yearUpon completion of the examination, record the rate of completion
Sedation during PET/MR examinations1 yearUpon completion of the examination, record the rate of sedation and rate of secondary sedation
Qualitative image quality1 yearTwo experienced nuclear medicine physicians evaluated the overall quality of the images using a Likert 5-point scale for both the new imaging PET/MR protocol and the traditional imaging protocol.

Countries

China

Contacts

Primary ContactJiajia Hu
jiajiahu@shsmu.edu.cn13524945287

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026